We previously showed that in the colorectal cancer (CRC) cell line HCT116, SN38 (the active metabolite of irinotecan) induces the activation of AKT and MEK, with an increase of their phosphorylation by 2- and 7-fold, respectively [23]. Here, MAP2K7 is linked to colorectal carcinoma.